Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04423796
Other study ID # ROBEM I
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 13, 2020
Est. completion date September 12, 2022

Study information

Verified date September 2023
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Feasibility trial investigating robotic assisted early mobilization vs. early mobilization in critically ill patients.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date September 12, 2022
Est. primary completion date August 14, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Invasive mechanically ventilated and expected to be ventilated for another 24 hours - Cardiovascular stability, allowing mobilization - Respiratory stability, allowing mobilization Exclusion Criteria: - Bed-bound before ICU admission - Bed-rest order or contraindication of weight load of the lower extremity or spine - Severe skin lesions or fasciitis in the area of contact with the device or rhabdomyolysis - Fresh SAB, ICB or elevated ICP - Status epilepticus - Acute intoxication - Shock with catecholamine doses >0.3µg/kg/min or acute bleeding including organ ruptures - Multiorgan failure with lactate > 4 mmol/l - Body height outside the range 150-195 cm - Body weight outside the range 45-135 kg - pAVK IV° - Pacemakers or other electrical stimulators - Implanted medical pumps - Pregnancy - Life expectancy below 7 days or acute palliative care situation - Death inevitable or maximum therapy is not carried out by the treating physicians or due to patient's request - Unable to understand the official language - ICU stay > 72h at the time of enrolment Translated with www.DeepL.com/Translator (free version)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Robotic-assisted early mobilization
The early mobilization is done by robotic assistance devices.
Other:
Early mobilization
Early mobilization by health care professionals without robotic assistance.

Locations

Country Name City State
Germany Charité - Univiversitätsmedizin Berlin Berlin-Mitte Berlin

Sponsors (2)

Lead Sponsor Collaborator
Charite University, Berlin, Germany Reactive Robotics GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of early mobilization Frequency of early mobilization performed by one health care provider during mechanical ventilation Up to Day 5
Secondary Mobilization level Mobilization level during mechanical ventilation using the ICU Mobility Scale (IMS) ranging from 0-10 up to Day 5
Secondary Mobilization duration Duration of mobilzation sessions during mechanical ventilation up to Day 5
Secondary Frequency of mobilization Frequency of early mobilization during mechanical ventilation up to Day 5
Secondary Pain level Pain level at mobilization using a numerical scale (NRS 0-10) or BPS 3-12 up to Day 5
Secondary Anxiety Anxiety due to mobilization using a numerical scale (NRS 0-10) up to Day 5
Secondary Patient satisfaction with mobilization Satisfaction with mobilization using a numerical scale (NRS 0-10) Up to Day 5
Secondary Inflammatory response Zytokin change from before to after mobilization Up to Day 5
Secondary Health care provider assessment Assessment of the satisfaction with the mobilization by the health care provider using Likert-Scales (1-5) Up to Day 5
Secondary Muscle wasting Muscle wasting will be assessed using ultrasound measurement of the M. femoris Up to Day5
Secondary Oxygen consumption during mobilization Oxygen consupmtion during mobilization will be measured using calorimetrie during mobilization Up to Day 5
Secondary Oesophageal pressure Oesophageal pressure will be measured during mobilization Up to Day 5
Secondary Safety events Frequency of safety events during mobilization Up to Day 5
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness